30.08.2010 • News

No Threat From Potash Bid Battle

Potash miner K+S is specialised enough to weather any takeover of Canadian rival Potash and survive as a standalone entity, the German firm's finance director told a newspaper.

Potash is facing a hostile $39 billion bid from BHP Billiton. The Canadian firm's shares have traded well above the $130 that the offer represents, suggesting investors believe BHP will boost its offer or a rival bidder will emerge. "We are following the latest developments ... calmly," Jan Peter Nonnenkamp told Boersen Zeitung newspaper in an interview published on Saturday.

Asked if K+S, the world's fourth-largest potash miner, should act to ensure it does not become a takeover target, he said: "A change of ownership at (Potash) would not create new capacity."

"The worldwide potash market would continue to offer sufficient space for K+S. That is true for standard products, but particularly more so for our  specialty products," he said. "In the past few years, K+S was able to assert itself very successfully against export cartels like Canpotex or BPC."

Nonnenkamp said K+S would continue to create value for shareholders, which was "the best protection against takeovers."

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read